Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
IND
Biotech
Denali ph. 1 Pompe plans hit with clinical hold
Denali does not expect the hold to delay its plans, and still intends to submit a clinical trial application in Europe in the first half of 2026.
Darren Incorvaia
Dec 4, 2025 11:52am
FDA proposes higher fees for ph. 1 trials conducted outside of US
Dec 3, 2025 5:19pm
After delay, Coya receives FDA go-ahead for phase 2 ALS trial
Aug 25, 2025 11:04am
FDA plans to end animal testing for new monoclonal antibody INDs
Apr 11, 2025 1:22pm
Empress' crown slips as biotech lays off over half of workers
Mar 18, 2025 1:20pm
Affini-T plans to go public in 2024
Jul 25, 2023 2:42pm